-+ 0.00%
-+ 0.00%
-+ 0.00%

NervGen Pharma switches auditor to KPMG US from KPMG Canada

PUBT·09/24/2026 12:28:22
Listen to the news
NervGen Pharma switches auditor to KPMG US from KPMG Canada
  • NervGen Pharma will replace KPMG Canada with KPMG US as its auditor effective Sept. 15, 2026.
  • KPMG Canada resigned at the company’s request.
  • No modified audit opinions were issued for the past two completed financial years through the effective date.
  • Management reported no reportable events tied to those audits through the effective date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NervGen Pharma Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-110225), on September 24, 2026, and is solely responsible for the information contained therein.